MDNA55

· Medicenna Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDNA55, covering 2022-10-24 to 2022-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma [Phase 2]